hVIVO is developing further capability & capacity in its unique Human Challenge facilities to assist in the advancement of novel antimalarial drug and vaccine candidates

hVIVO is developing the worlds first COVID-19 human challenge model in partnership with the UK Government as part of the Human Challenge Programme

A highly specialised virology and immunology laboratory offering a suite of services to support pre-clinical and clinical respiratory drug and vaccine discovery and development.

Volunteers are vital to the work we do. Thousands of people have already taken part in our ethically and regulatory approved clinical studies. Find out how you could join them.